EVENT DETAILS
02/10/21 2:30 PM EST
|
||
Title | 17th Annual WORLDSymposium™ 2021 | |
Date and Time | 02/10/21 2:30 PM EST | |
Description |
Title: Switching from agalsidase alfa to pegunigalsidase alfa to treat patients with Fabry disease: 1 year of treatment data from BRIDGE, a phase 3 open-label study Presenter: Ales Linhart, MD, Charles University, Praha, Czech Republic, a principal investigator in the Company's Phase III clinical trials of PRX-102 for the potential treatment of Fabry disease Date/Time: The oral presentation is scheduled for Wednesday, February 10, 2021 at 1:24 PM EST The poster presentation is scheduled for Wednesday, February 10, 2021 from 2:30 to 3:30 PM EST (Poster # 141) |